Piramal Pharma: 6th AGM notice and FY2026 Annual Report filed
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Piramal Pharma filed the 6th AGM notice and Annual Report for FY2025-26. AGM is scheduled for July 30, 2026 at 3:00 PM via video conferencing. FY26 highlights: Revenue from Operations Rs 8,869 Cr, Gross Contribution Rs 5,631 Cr, EBITDA Rs 1,135 Cr, Capital Expenditure Rs 890 Cr. Segment revenue: CDMO Rs 4,915 Cr (55 percent), Critical Care Rs 2,703 Cr (30 percent), Consumer Healthcare Rs 1,274 Cr (14 percent). Management calls FY26 a transitional year hit by inventory destocking and soft early-stage CDMO orders, with H2 recovery and broad-based growth expected in FY27.
Routine AGM filing. FY26 was a soft transitional year; recovery in CDMO order inflows and FY27 growth guidance are mildly positive signals.